Belén Requena | Biotechnology | Research Excellence Award

Published on by Popular Engineer

Dr. Belén Requena | Biotechnology | Research Excellence Award

San Pablo CEU University | Spain

Belén Paula Fernández Requena is a biotechnologist and academic researcher specializing in metabolomics, bioanalysis, lipid metabolism, and advanced imaging technologies. She holds a Bachelor’s degree in Biotechnology, a Master’s degree in Genetics and Cellular Biology, and a PhD in Health Sciences and Technology from CEU San Pablo University, where she is currently a full-time Profesor Contratado. Her doctoral work was conducted within the Excellence Research Group in Metabolomics and Bioanalysis (CEMBIO), focusing on molecular and metabolic mechanisms relevant to human health. Her international research experience spans leading European institutions, including Julius-Maximilians Universität Würzburg, IMDEA Food Institute, and Maastricht University, where she trained in single-cell imaging under the supervision of Prof. Ron Heeren. Her research interests include lipidomics, epigenetic regulation of metabolism, extracellular vesicles, plant and insect signaling mechanisms, and host–pathogen interactions, particularly lipid alterations associated with Leishmania infection and therapeutic response. Her work has contributed to interdisciplinary advances across biotechnology, molecular biology, and translational health research. Through sustained international collaboration and methodological innovation, she continues to advance metabolomics-driven approaches with long-term impact in biomedical and biotechnological sciences.


View Orcid Profile

Featured Publications


Plasma miRNA–Metabolite Dysregulation in People with HIV with Cirrhosis Despite Successful HCV Cure
Ana Virseda-Berdices, Raquel Behar-Lagares, Juan Berenguer, Juan González-García, Belén Fernández Requena et al.,
Pharmaceuticals, 2026. (Journal Article)

Addressing the Untargeted Lipidomics Challenge in Urine Samples: Comparative Study of Extraction Methods by UHPLC-ESI-QTOF-MS
Belén Fernández Requena, Carolina González-Riaño, Coral Barbas,
Analytica Chimica Acta, 2024. (WOS)

Comprehensive Lipidomic Analysis Reveals Further Insights into the Molecular Mechanism of Podocyte Lipotoxicity in Alport Syndrome
Amir Shabaka, Belén Fernández Requena, Carolina González-Riaño et al.,
Nephrology Dialysis Transplantation, 2024. (WOS)

LiLA: Lipid Lung-Based ATLAS Built Through a Comprehensive Workflow Designed for Accurate Lipid Annotation
Belén Fernández Requena, Sajid Nadeem, Vineel P. Reddy et al.,
Communications Biology, 2024. (Nature Portfolio)

Ghasem Ahangari | Neuroscience | Excellence in Research

Published on by Popular Engineer

Prof. Ghasem Ahangari | Neuroscience | Excellence in Research

National Institute of Genetic Engineering and Biotechnology | Iran

Professor Ghasem Ahangari is a senior academic and research leader in medical biotechnology, molecular immunology, and neuroimmunogenetics, with more than three decades of sustained contributions to translational biomedical science.  He holds academic training in medical technology, hematology, and molecular clinical immunology, with advanced research experience in internationally recognized institutions, including the Karolinska Institute. His professional career includes long-term faculty appointments, departmental leadership, institute directorships, and coordination of national and international scientific programs. His research interests center on complex disorders such as cancer, autoimmune diseases, neuroimmune and psychosomatic conditions, inflammation, neurotransmitter receptor signaling, and molecular diagnostics, with increasing integration of artificial intelligence in medical research. Professor Ahangari has authored numerous high-impact journal articles, books, and patents, supervised graduate researchers, and organized major scientific workshops and symposia. He is a recipient of multiple academic and research awards from national and international scientific bodies. Overall, his career reflects a strong commitment to interdisciplinary research, academic leadership, and advancing precision medicine through molecular and systems-level approaches.

Citation Metrics (Google Scholar)

2000
1600
600
200
0

Citations
1998

Documents
29
h-index
19

Citations

Documents

h-index


View Google Scholar Profile

Featured Publications

Jun Hu | Medicine and Health Sciences | Research Excellence Award

Published on by Popular Engineer

Dr. Jun Hu | Medicine and Health Sciences | Research Excellence Award

Nanjing University of Chinese Medicine | China

Jun Hu is a medical researcher and lecturer specializing in Traditional Chinese Medicine (TCM)–based interventions for inflammatory and immune-mediated diseases. Trained as a Medical Doctor at Nanjing University of Chinese Medicine, Hu has developed a focused academic career combining mechanistic biomedical research with evidence-based evaluation of traditional therapies. His professional experience centers on teaching and research at a leading TCM institution, where he contributes to both undergraduate and postgraduate medical education while leading interdisciplinary studies. Hu’s research interests include herbal formulas, electroacupuncture, acupoint application, and moxibustion, with particular emphasis on asthma, rheumatoid arthritis, neuroinflammation, and immune regulation. He has played a key role in nationally funded research, including a National Natural Science Foundation of China project investigating autophagy-dependent ferroptosis mechanisms in moxibustion therapy for rheumatoid arthritis synovitis. His scholarly output includes peer-reviewed articles in high-impact journals such as Biomolecules, Frontiers in Pharmacology, Mediators of Inflammation, and Journal of Ethnopharmacology. With an h-index of 7, more than 11 scientific publications, and over 95citations, his work demonstrates sustained academic influence. Overall, Jun Hu’s research bridges traditional medical theory and modern molecular science, advancing integrative strategies for chronic inflammatory disease management.

Citation Metrics (Scopus)

1200
1000
600
200
0

Citations
95

Documents
11
h-index
7

Citations

Documents

h-index


View Scopus Profile

Featured Publications


Qufeng Xuanbi Formula inhibits benzo[a]pyrene-aggravated asthma via the AhR/ROS/ERK pathway

Journal of Ethnopharmacology, 2024 · DOI: 10.1016/j.jep.2023.117203

Manouchehr Fadaee | Medicine and Health Sciences | Best Researcher Award

Published on by Popular Engineer

Dr. Manouchehr Fadaee | Medicine and Health Sciences | Best Researcher Award

Tabriz University of Medical Sciences | Iran

Dr. Manouchehr Fadaee is an accomplished researcher recognized for his contributions to microbiology, immunology, cancer biology, and host–pathogen interactions.  demonstrating consistent productivity and influence in the field. His academic journey is rooted in biomedical sciences, where he advanced his expertise in immunotherapy, cancer progression, gut microbiome, infectious diseases, and exosome-mediated communication. Dr. Fadaee has experience collaborating with international journals, contributing impactful reviews and original research articles in leading platforms such as Journal of Drug Targeting, Cancer Cell International, Cell Communication and Signaling, Breast Cancer Research, and American Journal of Reproductive Immunology. His research interests span exosome-based therapies, postbiotics, gut microbiota, autoimmunity, cancer immunotherapy, and novel antimicrobial strategies. Beyond research, he has actively served as a peer reviewer for journals including Journal of Drug Targeting and Cell Biology International, enhancing the quality of scientific discourse. With several impactful works on immunotherapy and microbial interventions, Dr. Fadaee continues to advance innovative approaches to combat cancer and infectious diseases, making him a promising leader in biomedical research.

Profile : Orcid

Featured Publications

“The Cytotoxic and Immune‐Regulatory Roles of CD8+T Cell‐Derived Exosomes in Cancer: A Systematic Review”

“Gut microbiome and colorectal cancer: From pathogenesis to treatment”

“Potential of Vaginal Microbiota Transplantation (VMT) in Endometritis Management”

“Cyclophosphamide‐Induced Infertility and the Impact of Antioxidants”

“Exosome therapeutics for non-small cell lung cancer tumorigenesis”

Aris Bechlioulis | Medicine and Health Sciences | Best Researcher Award

Published on by Popular Engineer

Dr Aris Bechlioulis | Medicine and Health Sciences | Best Researcher Award

University Hospital of Ioannina| Greece

Dr. Aris Bechlioulis is a distinguished cardiologist and academic, serving as an Attending Physician at the 2nd Department of Cardiology, University Hospital of Ioannina. He obtained his MD from the University of Ioannina, followed by a PhD on the impact of genetic polymorphisms of estrogen receptors on the cardiovascular system, and later achieved diplomas and certifications in cardiology, pacing, life support, and heart failure management from leading European institutions. His professional journey includes fellowships at the General Hospital of Arta and the University Hospital of Ioannina, and since 2016, he has contributed to the Heart Failure Unit with expertise in rhythm device implantation and advanced cardiovascular care. Dr. Bechlioulis has authored over 60 peer-reviewed articles, contributed to several book chapters, and presented more than 90 abstracts at national and international congresses. His academic influence is demonstrated by an h-index of 22, more than 1493 citations, and 86 indexed documents in Scopus. His primary research interests include heart failure, atrial fibrillation, vascular function, myocardial ischemia, biomarkers, and cardiac pacing. In recognition of his scholarly contributions, he has actively participated in European projects such as HORIZON 2020 and international clinical trials. His career reflects a commitment to advancing cardiovascular science and improving patient outcomes.

Profiles: Scopus | Orcid

Featured Publications

“Myocardial deformation and pro-arrhythmic indices in first-episode patients with psychosis before and one year after the initiation of antipsychotic treatment”

“Clinical Characteristics and Outcomes of Patients Admitted in Cardiac Intensive Care Unit with Cardiogenic Shock: A Single-Center Study”

“Depression and anxiety in Greek patients who received an implantable cardioverter-defibrillator and did not have shock therapy during a 12-month follow-up”

“Atrial Fibrillation as an Independent Predictor of Myocardial Ischemia”

“Identification of Novel Independent Correlations between Cellular Components of the Immune System and Strain-Related Indices of Myocardial Dysfunction in CKD Patients and Kidney Transplant Recipients without Established Cardiovascular Disease”